Typhoid Fever in Group Travelers: Opportunity for Studying Vaccine Efficacy | Zendy

Frank Cobelens | Zendy; S. van der Kooij | Zendy; Anita A. WarrisVersteegen | Zendy; Leo G. Visser | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Typhoid Fever in Group Travelers: Opportunity for Studying Vaccine Efficacy

Author(s) -

Frank Cobelens,

S. van der Kooij,

Anita A. WarrisVersteegen,

Leo G. Visser

Publication year - 2006

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.2310/7060.2000.00005

Subject(s) - medicine , typhoid fever , epidemiology , salmonella typhi , vaccination , immunization , attack rate , cohort , immunology , antigen , virology , biology , biochemistry , escherichia coli , gene

Typhoid fever (TF) is a rare disease among travelers to endemic areas, and little is known about its travel-related epidemiology. In addition, efficacy data on TF vaccines in travelers is scanty. During 3 months of 1994/95, six cases of TF were reported in The Netherlands among participants of four package tours to Indonesia provided by the same operator. The present study was designed to describe the epidemiology of TF in these groups, and to assess whether travel groups can be used for studying the efficacy of TF vaccines in travelers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research